Figure 7From: The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention Administration of PAI-1dp reduces T-cell reactivity towards MOG 35-55 peptide. A. PAI-1dp pre-treatment reduced T cell proliferation induced by MOG35-55. B. Reduced secretion of the pro-inflammatory cytokines IFN-γ and IL-17. The results are the mean standard error (SE) of three separate experiments (*P<0.05).Back to article page